Drug Research
NCCS and tech firm to collaborate on Asian-prevalent cancer research
Agilent Technologies Inc. recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years.
The scope of the...
Drug Research
Bharat Serums and Vaccines invests Rs 200 Cr in new biopharmaceutical manufacturing plant in Genome Valley
Bharat Serums and Vaccines Limited (BSV) hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telangana, in the presence of K.T Rama Rao, Minister for Municipal Administration and Urban Development; Industries and Commerce; and...
Drug Research
Sygnature Discovery successfully identifies potent SHP2 degrader compounds in collaboration with UBE Corporation
Sygnature Discovery and UBE Corporation have begun a collaboration on a Hit-to-Lead program to identify SHP2 degraders.
SHP2 is a tyrosine-specific phosphatase implicated in human cancers and the objective is to develop potent bifunctional compounds with excellent ADME and PK...
Drug Research
Growing Demand Reshaping The Future of Aseptic Fill Finish
It's important to highlight that aseptic fill finish operations demand skilled personnel, specialized automated equipment, a controlled cleanroom environment, and constant supervision to maintain the sterility and safety of the final pharmaceutical product.
Nevertheless, due to the high costs associated...
BioPharma
Biotech Innovations In The Face of Economic Uncertainty
While the pharmaceutical industry has traditionally been seen as recession-proof, with a constant demand for medicines and new treatment options, it currently faces significant challenges. Economic uncertainty is on the rise, increasing the risks associated with early drug discovery,...
Drug Research
Sever Pharma Solutions breaks ground with new high potency drug manufacturing suites
Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI) manufacturing suites. The company’s investment in these new state-of-the-art manufacturing facilities will allow them...
Drug Research
Bora merges with Sunway Biotech to launch global Nutraceuticals offering
Bora Health, a global design, development and distribution partner of pharmaceuticals and health foods and part of the Bora group, has announced its merged with Sunway Biotech, a leading ingredients manufacturer, and research and development (R&D) organization. Resulting in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















